Advertisement
UK markets close in 14 minutes

  • FTSE 100

    8,436.87
    +55.52 (+0.66%)
     

  • FTSE 250

    20,642.26
    +110.96 (+0.54%)
     

  • AIM

    789.92
    +6.22 (+0.79%)
     

  • GBP/EUR

    1.1612
    +0.0001 (+0.01%)
     

  • GBP/USD

    1.2511
    -0.0013 (-0.10%)
     

  • Bitcoin GBP

    48,653.88
    -793.21 (-1.60%)
     

  • CMC Crypto 200

    1,266.70
    -91.31 (-6.71%)
     

  • S&P 500

    5,217.54
    +3.46 (+0.07%)
     

  • DOW

    39,471.27
    +83.51 (+0.21%)
     

  • CRUDE OIL

    79.23
    -0.03 (-0.04%)
     

  • GOLD FUTURES

    2,365.00
    +24.70 (+1.06%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,773.53
    +86.93 (+0.47%)
     

  • CAC 40

    8,224.23
    +36.58 (+0.45%)
     
MONEY:

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

GlaxoSmithKline chairman says break-up not on the cards

Reuters - UK Focus

LONDON, May 5 (Reuters) - GlaxoSmithKline (Other OTC: GLAXF - news) 's chairman said on Thursday that a break-up of the pharmaceuticals group is not something that is being considered at all at present.

Philip Hampton said at GSK's annual meeting that the focus was instead on boosting the performance of the group's consumer division, which sells products ranging from headache pills to toothpaste.

Britain's biggest drugmaker is in the process of seeking a new chief executive and is under pressure from some shareholders to consider breaking up and spinning off consumer health. (Reporting by Ben Hirschler; Editing by Alexander Smith)